Ispire Q3 Report: Revenue and Profit Grow with Cannabis Focus

Business by Vincent Yi; Ellesmere Zhu
May.17.2023
Ispire Q3 Report: Revenue and Profit Grow with Cannabis Focus
E-vapor firm Ispire reports a 26.9% year-on-year revenue growth in Q3, according to the company's 10-Q report.

E-vapor company Ispire has reported a 26.9% year-on-year growth in its revenue for the third quarter of 2023, reaching $24.1 million, as per its 10-Q report submitted to the U.S. Securities and Exchange Commission (SEC) on May 15, 2023. Gross profit for the same period saw a 51.9% increase, hitting $4.5 million. Notably, Ispire's fiscal year ends on June 30th, not the traditional December 31st.

 

According to CFO Michael Wang, the firm anticipates a 58% to 98% sequential revenue growth from cannabis-related products in the fourth quarter. "We're focused on a multi-pronged strategy aimed at increasing the sales of our e-vapor products and developing CBD e-vapor products, with an emphasis on medical and recreational uses," Wang stated.

 

In Q3, Ispire's revenue from e-vapor products amounted to $16.5 million, while CBD-related vapor products contributed $7.6 million. The total operating costs grew 106.2% to $8 million, compared to $3.9 million in the same period of 2022. This led to a net loss of $3.1 million, a significant increase from the $1 million loss in Q3 2022.


Looking ahead, Ispire anticipates Q4 revenues from CBD vapor products to range from $12 million to $15 million, a 58% to 98% growth from Q3 2023. Ispire, which began marketing its CBD vapor products in mid-2020, is engaged in the research, design, commercialization, sales, promotion, and distribution of branded e-cigarettes and CBD vapor products. Its tobacco e-vapor products are sold under the brand name Aspire.


Thumbnail source: Ispire

*This article is an original article of 2FIRSTS Technology Co., Ltd. The copyright and license rights belong to the company. Any entity or individual shall make link and credit 2FIRSTS when taking actions to copy, reprint or distribute the original article. The company retains the right to pursue its legal responsibility.

U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”
U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”
At a policy forum hosted by The Hill and sponsored by PMI US, U.S. defense health officials, lawmakers and industry representatives discussed tobacco use in the military and explored the potential role of smoke-free nicotine products — including e-cigarettes and nicotine pouches — as transitional tools to help service members reduce reliance on combustible cigarettes.
PMI
Mar.23
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
U.S. Customs and Border Protection (CBP) announced that more than 18 million illegal e-cigarettes valued at over $175 million were seized during “Operation Red Mist,” a joint enforcement initiative involving the U.S. Coast Guard and the FDA. The operation primarily targeted maritime vape shipments originating from China and focused on combating illicit importation, transportation, and distribution activities.
Regulations
May.14
Special Report|From Nicotine Pouches to Jelly? A China Tobacco Patent Explores Dual-Release NRT
Special Report|From Nicotine Pouches to Jelly? A China Tobacco Patent Explores Dual-Release NRT
A patent published on February 24, 2026, by China Tobacco Hubei Industrial Co., Ltd. introduces a “nicotine jelly” product designed to combine rapid and sustained nicotine delivery. By integrating both free and microencapsulated nicotine, the product aims to address key limitations of traditional nicotine replacement therapy (NRT), while also raising new regulatory and product classification questions.
Innovation
Mar.18
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
A new study analyzing National Health Interview Survey data found that adult cigarette smoking in the United States declined to 9.9% in 2024, down from 10.8% in 2023. The findings, published in NEJM Evidence, represent a historic milestone in U.S. tobacco control efforts. Researchers noted that while cigarette smoking is decreasing, the prevalence of e-cigarette and cigar use remained largely unchanged, suggesting a shift in nicotine consumption rather than the elimination of tobacco use.
Market
Mar.20
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
Special Report|Disposable Heated Tobacco? A China Tobacco Patent Reimagines the Heated-Tobacco Stick as a Self-Contained Product
Special Report|Disposable Heated Tobacco? A China Tobacco Patent Reimagines the Heated-Tobacco Stick as a Self-Contained Product
A newly published China Tobacco patent proposes a holder-free heat-not-burn stick that integrates the filter, tobacco substrate, heating element, controller and power source into one cigarette-shaped product. It stands out not just for eliminating the external heating device, but for explicitly highlighting two less common goals in heated tobacco: restoring cigarette-like social sharing and enabling post-use recovery through a recoverable component group.
Innovation
Mar.18